![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 3
2019
Guttman-Yassky, Emma; Hanifin, Jon M.; Boguniewicz, Mark; Wollenberg, Andreas; Bissonnette, Robert; Purohit, Vivek; Kilty, Iain; Tallman, Anna M. und Zielinski, Michael A.
(2019):
The role of phosphodiesterase 4 in the pathophysiology of atopic dermatitis and the perspective for its inhibition.
In: Experimental Dermatology, Bd. 28, Nr. 1: S. 3-10
2018
Kabashima, Kenji; Furue, Masutaka; Hanifin, Jon M.; Pulka, Grazyna; Wollenberg, Andreas; Galus, Ryszard; Etoh, Takafumi; Mihara, Ryosuke; Nakano, Miwa und Ruzicka, Thomas
(2018):
Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension study.
In: Journal of Allergy and Clinical Immunology, Bd. 142, Nr. 4: S. 1121-1130
2017
Ruzicka, Thomas; Hanifin, Jon M.; Furue, Masutaka; Pulka, Grazyna; Mlynarczyk, Izabela; Wollenberg, Andreas; Galus, Ryszard; Etoh, Takafumi; Mihara, Ryosuke; Yoshida, Hiroki; Stewart, Jonathan und Kabashima, Kenji
(2017):
Anti-Interleukin-31 Receptor A Antibody for Atopic Dermatitis.
In: New England Journal of Medicine, Bd. 376, Nr. 9: S. 826-835